Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Smart implant aims to dial down chronic pain for years

NCT ID NCT04627974

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a special spinal cord stimulator that automatically adjusts to your pain signals. It involves 70 adults with long-term pain in the back, arms, or legs. The goal is to see if the device safely reduces pain over time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

70 people

The number who actually took part.

Started

Aug 2020

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients with chronic trunk and/or limb pain.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Eligible for therapy according to the Evoke System indications for use statement and labelling requirements * Willing and capable of giving informed consent and able to comply with study-related requirements, procedures, and visits * Baseline VAS pain rating ≥60 mm in the primary area of pain Exclusion Criteria: * No further exclusion criteria

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic pain are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • AZ Delta Multidisciplinary Pain Center

    Roeselare, West Flanders, 8800, Belgium

  • AZ Nikolaas Multidisciplinary Pain Center

    Sint-Niklaas, East Flanders, 9100, Belgium

  • Basildon University Hospital

    Basildon, Essex, SS16 5NL, United Kingdom

  • Erasmus University Medical Center

    Rotterdam, 3015 GD, Netherlands

  • James Cook University Hospital

    Middlesbrough, North Yorkshire, TS4 3BW, United Kingdom

  • Rijnstate

    Velp, 6815 AD, Netherlands

  • Southmead Hospital

    Bristol, BS10 5NB, United Kingdom

  • Universität Düsseldorf

    Düsseldorf, North Rhine-Westphalia, 40225, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.